Provided by Tiger Trade Technology Pte. Ltd.

Insmed

100.48
-1.2600-1.24%
Post-market: 100.600.1200+0.12%16:54 EDT
Volume:5.25M
Turnover:522.20M
Market Cap:21.94B
PE:-24.58
High:101.06
Open:100.66
Low:96.68
Close:101.74
52wk High:212.75
52wk Low:90.39
Shares:218.38M
Float Shares:216.82M
Volume Ratio:1.38
T/O Rate:2.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0882
EPS(LYR):-6.4200
ROE:-87.22%
ROA:-22.17%
PB:28.97
PE(LYR):-15.65

Loading ...

Insmed CMO Martina Flammer Disposes of Common Shares Worth $1.35 Million

Reuters
·
Jul 09

Analysts Are Bullish on These Healthcare Stocks: Insmed (INSM), Biogen (BIIB)

TIPRANKS
·
Jul 07

Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD) and Insmed (INSM)

TIPRANKS
·
Jun 29

Insmed Chair and CEO William Lewis Disposes of Common Shares Worth $2.21 Million

Reuters
·
Jun 27

Is Insmed (INSM) Cheap Following The EMBARC Partnership And Upcoming TPIP Data?

Simply Wall St.
·
Jun 26

Insmed Files Form 3 for SVP, GM Global Respiratory Samuele Butera

Reuters
·
Jun 25

Insmed Chief Legal Officer Michael Alexander Smith Sells 1,806 Shares for $173,023.92

Reuters
·
Jun 25

Jefferies Reaffirms Their Buy Rating on Insmed (INSM)

TIPRANKS
·
Jun 23

Insmed names Samuele Butera SVP, GM of global respiratory unit

Reuters
·
Jun 23

Press Release: Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global Respiratory

Dow Jones
·
Jun 23

Insmed Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jun 23

U.S. RESEARCH ROUNDUP-CAMP4 Therapeutics, Rockwell Automation, Zions Bancorporation

Reuters
·
Jun 16

Insmed (INSM) Stock Valuation After Pullback And Rare Disease Pipeline Debate

Simply Wall St.
·
Jun 16

Mizuho cuts Insmed target, sees buying opportunity after selloff

TIPRANKS
·
Jun 15

Mizuho Securities Adjusts Price Target on Insmed to $192 From $202, Maintains Outperform Rating

MT Newswires Live
·
Jun 15

Insmed’s New TPIP Liver Study Marks a Small but Important De‑Risking Step

TIPRANKS
·
Jun 12

Movement Alert|Insmed Rises 5.95% in Regular Trading, PAH Inhalation Therapy Phase 3 Trial Shows Positive Progress

Market Focus
·
Jun 12

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-06-11

Reuters
·
Jun 11

U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle

Reuters
·
Jun 11

Insmed Inc : Guggenheim Cuts Target Price to $207 From $226

THOMSON REUTERS
·
Jun 11